Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leishmania donovani | 10 | 2021 | 65 | 3.110 |
Why?
|
| Leishmaniasis, Visceral | 10 | 2021 | 94 | 3.010 |
Why?
|
| Antiprotozoal Agents | 4 | 2021 | 86 | 1.160 |
Why?
|
| Electron Transport Complex III | 1 | 2019 | 31 | 0.700 |
Why?
|
| Amino Acids | 1 | 2019 | 1733 | 0.450 |
Why?
|
| Mice, Inbred BALB C | 8 | 2021 | 6380 | 0.390 |
Why?
|
| Macrophages | 4 | 2020 | 5651 | 0.380 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2023 | 985 | 0.310 |
Why?
|
| Mitochondria | 2 | 2019 | 3513 | 0.290 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4386 | 0.290 |
Why?
|
| Parasitic Sensitivity Tests | 2 | 2021 | 83 | 0.220 |
Why?
|
| Vero Cells | 2 | 2019 | 485 | 0.200 |
Why?
|
| Sizofiran | 1 | 2020 | 2 | 0.200 |
Why?
|
| Interferon-gamma | 2 | 2020 | 3205 | 0.200 |
Why?
|
| Protozoan Vaccines | 1 | 2020 | 13 | 0.200 |
Why?
|
| Structure-Activity Relationship | 3 | 2021 | 3128 | 0.180 |
Why?
|
| Immune Evasion | 2 | 2020 | 360 | 0.170 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2020 | 708 | 0.170 |
Why?
|
| Molecular Structure | 2 | 2021 | 1894 | 0.160 |
Why?
|
| Cricetinae | 2 | 2019 | 2475 | 0.160 |
Why?
|
| Antigens, Protozoan | 1 | 2020 | 322 | 0.160 |
Why?
|
| Metronidazole | 1 | 2019 | 217 | 0.160 |
Why?
|
| Ethylenes | 1 | 2017 | 39 | 0.160 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2017 | 93 | 0.150 |
Why?
|
| Interleukin-12 | 1 | 2019 | 577 | 0.150 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2018 | 262 | 0.150 |
Why?
|
| Interleukin-10 | 2 | 2020 | 1200 | 0.140 |
Why?
|
| Immunity, Cellular | 2 | 2020 | 1608 | 0.140 |
Why?
|
| Pyridones | 1 | 2021 | 711 | 0.140 |
Why?
|
| Spleen | 2 | 2019 | 2359 | 0.130 |
Why?
|
| Prostaglandin D2 | 1 | 2016 | 122 | 0.130 |
Why?
|
| Drug Design | 1 | 2021 | 1075 | 0.130 |
Why?
|
| Adjuvants, Immunologic | 1 | 2020 | 999 | 0.130 |
Why?
|
| Mice | 10 | 2023 | 81154 | 0.130 |
Why?
|
| Life Cycle Stages | 1 | 2016 | 159 | 0.130 |
Why?
|
| Protein Isoforms | 1 | 2019 | 1729 | 0.120 |
Why?
|
| Toll-Like Receptors | 1 | 2018 | 593 | 0.120 |
Why?
|
| Quinolines | 1 | 2019 | 732 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2021 | 2938 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2020 | 3504 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2019 | 4221 | 0.110 |
Why?
|
| Integrins | 1 | 2017 | 846 | 0.110 |
Why?
|
| Cell Communication | 1 | 2019 | 1621 | 0.110 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 18027 | 0.100 |
Why?
|
| Animals | 12 | 2023 | 168660 | 0.100 |
Why?
|
| Cells, Cultured | 4 | 2021 | 19232 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1789 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 10940 | 0.090 |
Why?
|
| Cell Survival | 1 | 2019 | 5881 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2020 | 1898 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2019 | 2720 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2077 | 0.080 |
Why?
|
| Immunity, Humoral | 2 | 2023 | 598 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2914 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2019 | 23398 | 0.070 |
Why?
|
| Cytokines | 1 | 2019 | 7324 | 0.060 |
Why?
|
| Germinal Center | 1 | 2023 | 377 | 0.050 |
Why?
|
| Mesocricetus | 1 | 2020 | 252 | 0.050 |
Why?
|
| Cell Differentiation | 3 | 2023 | 11478 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2020 | 241 | 0.040 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2020 | 211 | 0.040 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2018 | 78 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2018 | 320 | 0.040 |
Why?
|
| Amphotericin B | 1 | 2016 | 137 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 671 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 2016 | 162 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2017 | 294 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2019 | 2327 | 0.030 |
Why?
|
| Cricetulus | 1 | 2016 | 818 | 0.030 |
Why?
|
| Cell Line | 2 | 2020 | 15993 | 0.030 |
Why?
|
| Immunity | 1 | 2019 | 1013 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 2217 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2023 | 3476 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 2183 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1479 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2018 | 3000 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2018 | 2500 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2504 | 0.020 |
Why?
|
| Vaccination | 1 | 2020 | 3275 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 2006 | 0.020 |
Why?
|
| Kidney | 1 | 2023 | 7185 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 4931 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2018 | 8436 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3645 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4422 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2023 | 12209 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 10179 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13273 | 0.010 |
Why?
|
| Rats | 1 | 2019 | 24250 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9648 | 0.010 |
Why?
|
| Liver | 1 | 2016 | 7479 | 0.010 |
Why?
|
| Apoptosis | 1 | 2016 | 9718 | 0.010 |
Why?
|
| Humans | 2 | 2023 | 743811 | 0.010 |
Why?
|
| Female | 4 | 2019 | 380020 | 0.010 |
Why?
|
| Male | 3 | 2020 | 349776 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 63042 | 0.010 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_